Study on the, synthesis and anti-inflammatory and analgesic activities of the derivatives of ibuprofen

被引:0
|
作者
Guo, CB [1 ]
Chen, XH
Yi, X
Guo, ZR
Chu, FM
Cheng, GF
机构
[1] Chinese Acad Med Sci, Inst Mat Med, Beijing 100050, Peoples R China
[2] Peking Union Med Coll, Beijing 100050, Peoples R China
关键词
ibuprofen; cyclooxygenase-2; inhibitor; anti-inflammatory; analgesic;
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Based on the structural differences between cyclooxygenase-2 (COX-2) and COX-1, a series of ibuprofen derivatives was designed, in which, a substituted benzamido, group was introduced to the 3 position of the phenyl ring of ibuprofen. The purpose of this modification was to add a structural segment to occupy the side pocket in COX-2 so as to enhance their affinity for COX-2. The twelve target compounds were synthesized in five steps with ibuprofen as the starting material and structurally confirmed by H-1 NMR, MS and elemental analysis (or HRMS). The biological tests showed that some of them have inhibitory activity against COX-2 in vitro. Compounds 7g and 7h were evaluated in vivo and exhibited weak anti-inflammatory but potent analgesic activities.
引用
收藏
页码:841 / 848
页数:8
相关论文
共 10 条
  • [1] Indium/ammonium chloride mediated selective reduction of aromatic nitro compounds: Practical synthesis of 6-aminochrysene
    Banik, BK
    Suhendra, M
    Banik, I
    Becker, FF
    [J]. SYNTHETIC COMMUNICATIONS, 2000, 30 (20) : 3745 - 3754
  • [2] Structure-based design of COX-2 selectivity into flurbiprofen
    Bayly, CI
    Black, WC
    Léger, S
    Ouimet, N
    Ouellet, M
    Percival, MD
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (03) : 307 - 312
  • [3] COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: Cloning, structure, and expression
    Chandrasekharan, NV
    Dai, H
    Roos, KLT
    Evanson, NK
    Tomsik, J
    Elton, TS
    Simmons, DL
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (21) : 13926 - 13931
  • [4] de Leval X, 2000, CURR MED CHEM, V7, P1041
  • [5] The development of COX2 inhibitors
    Flower, RJ
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (03) : 179 - 191
  • [6] Aspirin-like molecules that covalently inactivate cyclooxygenase-2
    Kalgutkar, AS
    Crews, BC
    Rowlinson, SW
    Garner, C
    Seibert, K
    Marnett, LJ
    [J]. SCIENCE, 1998, 280 (5367) : 1268 - 1270
  • [7] Ester and amide derivatives of the nonsteroidal antiinflammatory drug, indomethacin, as selective cyclooxygenase-2 inhibitors
    Kalgutkar, AS
    Marnett, AB
    Crews, BC
    Remmel, RP
    Marnett, LJ
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (15) : 2860 - 2870
  • [8] Lumiracoxib.: Antiarthritic, COX-2 inhibitor
    Sorbera, LA
    Castañer, J
    Bayés, M
    Silvestre, JS
    [J]. DRUGS OF THE FUTURE, 2002, 27 (08) : 740 - 747
  • [9] Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity:: A full in vitro analysis
    Warner, TD
    Giuliano, F
    Vojnovic, I
    Bukasa, A
    Mitchell, JA
    Vane, JR
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (13) : 7563 - 7568
  • [10] EXPRESSION OF A MITOGEN-RESPONSIVE GENE ENCODING PROSTAGLANDIN SYNTHASE IS REGULATED BY MESSENGER-RNA SPLICING
    XIE, WL
    CHIPMAN, JG
    ROBERTSON, DL
    ERIKSON, RL
    SIMMONS, DL
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (07) : 2692 - 2696